Plasma Exchange Versus Intravenous Immunoglobulin in Children with Guillain Barré Syndrome
Objective : To compare the outcome of plasma exchange versus intravenous immunoglobulin among children with Guillain Barre Syndrome. Methods : A randomized controlled trial was conducted at department of Pediatrics, National Institute of Child Health, Karachi from August 2016 to February 2017. All...
Main Authors: | , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Dow University of Health Sciences
2019-12-01
|
Series: | Journal of the Dow University of Health Sciences |
Subjects: | |
Online Access: | http://www.jduhs.com/index.php/jduhs/article/view/850 |
_version_ | 1818499697439932416 |
---|---|
author | Erum Elahi Muhammad Ashfaq Bader U Nisa Saadullah Chachar |
author_facet | Erum Elahi Muhammad Ashfaq Bader U Nisa Saadullah Chachar |
author_sort | Erum Elahi |
collection | DOAJ |
description | Objective : To compare the outcome of plasma exchange versus intravenous immunoglobulin among children with Guillain Barre Syndrome.
Methods : A randomized controlled trial was conducted at department of Pediatrics, National Institute of Child Health, Karachi from August 2016 to February 2017. All patients of age ranged from 2-15 years of either gender having duration of Guillain Barre Syndrome not more than 14 days were included. The children were divided into plasma exchange or intravenous immunoglobulin group. Intravenous immunoglobulin was administered for five days in a dose of 0.4 g/kg/day/ while a daily one-volume plasma exchange was given to patients in the plasma exchange group for five days. Duration of mechanical ventilation and the pediatric intensive care unit stay in days were noted.
Results
Of 78 children, the mean age was 6.64 ±3.06 years. There were 47 (60.3%) males and 31 (39.7%) females. A significantly higher length of intensive care unit stay was noted among children who received plasma exchange (9.45 ±4.59 days) as compared to the children who received intravenous immunoglobin (4.97 ±2.84 days) (p-value <0.001, 95% CI -6.23 to -2.73). Similarly, the mean duration of ventilator stay was significantly higher among children who received plasma exchange (7.33 ±3.44 days) as compared to the children who received intravenous immunoglobin (2.01 ±0.01 days) (p-value <0.001, -7.91 to -2.74).
Conclusion : The outcome of intravenous immunoglobin founds better than that of plasma exchange in treating children with Guillain Barre syndrome. |
first_indexed | 2024-12-10T20:32:58Z |
format | Article |
id | doaj.art-e3337c0dd94347e8b251403de6064caa |
institution | Directory Open Access Journal |
issn | 1995-2198 2410-2180 |
language | English |
last_indexed | 2024-12-10T20:32:58Z |
publishDate | 2019-12-01 |
publisher | Dow University of Health Sciences |
record_format | Article |
series | Journal of the Dow University of Health Sciences |
spelling | doaj.art-e3337c0dd94347e8b251403de6064caa2022-12-22T01:34:38ZengDow University of Health SciencesJournal of the Dow University of Health Sciences1995-21982410-21802019-12-0113313313710.36570/jduhs.2019.3.693850Plasma Exchange Versus Intravenous Immunoglobulin in Children with Guillain Barré SyndromeErum Elahi0Muhammad Ashfaq1Bader U Nisa2Saadullah Chachar3NICHNICHNICHNICHObjective : To compare the outcome of plasma exchange versus intravenous immunoglobulin among children with Guillain Barre Syndrome. Methods : A randomized controlled trial was conducted at department of Pediatrics, National Institute of Child Health, Karachi from August 2016 to February 2017. All patients of age ranged from 2-15 years of either gender having duration of Guillain Barre Syndrome not more than 14 days were included. The children were divided into plasma exchange or intravenous immunoglobulin group. Intravenous immunoglobulin was administered for five days in a dose of 0.4 g/kg/day/ while a daily one-volume plasma exchange was given to patients in the plasma exchange group for five days. Duration of mechanical ventilation and the pediatric intensive care unit stay in days were noted. Results Of 78 children, the mean age was 6.64 ±3.06 years. There were 47 (60.3%) males and 31 (39.7%) females. A significantly higher length of intensive care unit stay was noted among children who received plasma exchange (9.45 ±4.59 days) as compared to the children who received intravenous immunoglobin (4.97 ±2.84 days) (p-value <0.001, 95% CI -6.23 to -2.73). Similarly, the mean duration of ventilator stay was significantly higher among children who received plasma exchange (7.33 ±3.44 days) as compared to the children who received intravenous immunoglobin (2.01 ±0.01 days) (p-value <0.001, -7.91 to -2.74). Conclusion : The outcome of intravenous immunoglobin founds better than that of plasma exchange in treating children with Guillain Barre syndrome.http://www.jduhs.com/index.php/jduhs/article/view/850plasma exchangeintravenous immunoglobulinchildren, guillain barré syndrome |
spellingShingle | Erum Elahi Muhammad Ashfaq Bader U Nisa Saadullah Chachar Plasma Exchange Versus Intravenous Immunoglobulin in Children with Guillain Barré Syndrome Journal of the Dow University of Health Sciences plasma exchange intravenous immunoglobulin children, guillain barré syndrome |
title | Plasma Exchange Versus Intravenous Immunoglobulin in Children with Guillain Barré Syndrome |
title_full | Plasma Exchange Versus Intravenous Immunoglobulin in Children with Guillain Barré Syndrome |
title_fullStr | Plasma Exchange Versus Intravenous Immunoglobulin in Children with Guillain Barré Syndrome |
title_full_unstemmed | Plasma Exchange Versus Intravenous Immunoglobulin in Children with Guillain Barré Syndrome |
title_short | Plasma Exchange Versus Intravenous Immunoglobulin in Children with Guillain Barré Syndrome |
title_sort | plasma exchange versus intravenous immunoglobulin in children with guillain barre syndrome |
topic | plasma exchange intravenous immunoglobulin children, guillain barré syndrome |
url | http://www.jduhs.com/index.php/jduhs/article/view/850 |
work_keys_str_mv | AT erumelahi plasmaexchangeversusintravenousimmunoglobulininchildrenwithguillainbarresyndrome AT muhammadashfaq plasmaexchangeversusintravenousimmunoglobulininchildrenwithguillainbarresyndrome AT baderunisa plasmaexchangeversusintravenousimmunoglobulininchildrenwithguillainbarresyndrome AT saadullahchachar plasmaexchangeversusintravenousimmunoglobulininchildrenwithguillainbarresyndrome |